GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the …
MarketWatch 20, 2014 /PRNewswire/ — GlaxoSmithKline plc today announced that the FDA has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of asthma as prophylactic … |
View full post on asthma – Google News